Skip to main content
. 2021 Jan 17;22(2):888. doi: 10.3390/ijms22020888
ASCO American Society of Clinical Oncology
ATF3 Activating transcription factor 3
BIPN Bortezomib-induced peripheral neuropathy
CCL CC chemokine ligand
CIPN Chemotherapy-induced peripheral neuropathy
Cmax Maximum blood concentration
CNS Central nervous system
DRG Dorsal root ganglia
ER Endoplasmic reticulum
ERK Extracellular signal-regulated protein kinase
FDA the US Food and Drug Administration
GFAP Glial fibrillary acidic protein
GLAST Glutamate/aspartate transporter
IENF Intraepidermal nerve fiber
IL Interleukin
JNK c-Jun N-terminal kinase
MAPK Mitogen-activated protein kinase
mEPSCs Miniature excitatory postsynaptic currents
NAD+ Nicotinamide adenine dinucleotide
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
NLRP3 NOD-like receptor family pyrin domain containing 3
PNS Peripheral nervous system
PKC Protein kinase C
ROS Reactive oxygen species
SARM1 Sterile alpha and toll/interleukin-1 receptor motif-containing 1
S1P Sphingosine-1-phosphate
S1PR Sphingosine-1-phosphate receptor
STAT3 Signal transducer and activator of transcription-3
TNF-α Tumor necrosis factor alpha
TRPA1 Transient receptor potential ankyrin 1